Gregory P Kaufman

Assistant Professor

  • 163 Citations
  • 6 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gregory P Kaufman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Amyloidosis Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Cell Cycle Checkpoints Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences
Tissue Survival Medicine & Life Sciences
Pancytopenia Medicine & Life Sciences
Proteasome Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

  • 163 Citations
  • 6 h-Index
  • 7 Article
  • 2 Letter
  • 1 Review article
1 Citation (Scopus)

Grading cardiac response in AL amyloidosis: implications for relapse and survival

Eckhert, E., Witteles, R., Kaufman, G., Lafayette, R., Arai, S., Schrier, S., O'Shaughnessy, M. & Liedtke, M., Jul 2019, In : British Journal of Haematology. 186, 1, p. 144-146 3 p.

Research output: Contribution to journalLetter

Open Access
1 Citation (Scopus)

Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases

Atallah-Yunes, S. A., Kadado, A. J., Kaufman, G. P. & Hernandez-Montfort, J., Jun 1 2019, In : Journal of cancer research and clinical oncology. 145, 6, p. 1527-1557 31 p.

Research output: Contribution to journalReview article

Heart Block

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Dinner, S., Dunn, T. J., Price, E., Coutré, S. E., Gotlib, J., Berube, C., Kaufman, G. P., Medeiros, B. C. & Liedtke, M., Sep 1 2018, In : International journal of hematology. 108, 3, p. 267-273 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Maximum Tolerated Dose
61 Citations (Scopus)

Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis

Kaufman, G. P., Schrier, S. L., Lafayette, R. A., Arai, S., Witteles, R. M. & Liedtke, M., Aug 17 2017, In : Blood. 130, 7, p. 900-902 3 p.

Research output: Contribution to journalArticle

Open Access
Immunoglobulin Light Chains
Monoclonal Antibodies
10 Citations (Scopus)

Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells

Gu, J. J., Kaufman, G. P., Mavis, C., Czuczman, M. S. & Hernandez-Ilizaliturri, F. J., Jan 1 2017, In : Oncotarget. 8, 8, p. 12741-12753 13 p.

Research output: Contribution to journalArticle

Open Access
B-Cell Lymphoma
Cell Cycle Checkpoints
Cell Death
Cell Line